Dr Barbara Pro is a clinical esearcher and Professor of Medicine at Columbia University, Irving Medical Center, in the
Division of Hematology and Oncology, and the Director of the Lymphoma program. Throughout her career she has focused
on developing new and improved therapies for patients with B cell and T-cell lymphoproliferative
disorders and has served as the PI on numerous clinical trials, including trials that led to FDA approval of
novel agents for the improved treatment of patients with these diseases. She has also served as Chief of the Lymphoma Section and Founding Director of the
Multidisciplinary CTCL program at the Kimmel Cancer Center at Thomas Jefferson University. She has been a member of
NCCN guidelines panel for T-cell lymphoma and PCBCL and the ECOG Lymphoma Core Committee.